BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bellera CL, Di Ianni ME, Talevi A. The application of molecular topology for ulcerative colitis drug discovery. Expert Opin Drug Discov 2018;13:89-101. [PMID: 29088918 DOI: 10.1080/17460441.2018.1396314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Belllera CL, Sbaraglini ML, Alberca LN, Alice JI, Talevi A. In Silico Modeling of FDA-Approved Drugs for Discovery of Therapies Against Neglected Diseases: A Drug Repurposing Approach. In Silico Drug Design. Elsevier; 2019. pp. 625-48. [DOI: 10.1016/b978-0-12-816125-8.00021-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Zanni R, Galvez-llompart M, Garcia-domenech R, Galvez J. What place does molecular topology have in today’s drug discovery? Expert Opinion on Drug Discovery 2020;15:1133-44. [DOI: 10.1080/17460441.2020.1770223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]